""

Carcinoma of Unknown Primary (CUP)

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

Title: A Phase II, Randomized, Active controlled, Multi-Center study comparing efficacy and safety of targeted therapy or cander immunotherapy guided by genomic profiling versus platinum-based chemotherapy in patinets with CUP who have received three cycles of platinum doublet chemotherapy
Phase: II
Contact: Marie-Christin Vollmer / Study Nurse
Clinical Investigator: Prof. Dr. Alwin Krämer
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03498521
EudraCT-Number: (siehe EU klinisches Studienregister) 2017-003040-20

Metastatic Disease: Follow-Up Treatment

There are currently no studies available

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

There are currently no studies available